Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2010 1
2011 2
2012 3
2013 3
2014 1
2015 1
2016 5
2017 6
2018 3
2019 3
2020 4
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
Ahumada A, Rayón L, Usón C, Bañares R, Alonso Lopez S. Ahumada A, et al. World J Gastroenterol. 2021 Oct 28;27(40):6737-6749. doi: 10.3748/wjg.v27.i40.6737. World J Gastroenterol. 2021. PMID: 34790004 Free PMC article. Review.
Not surprisingly, HCV infection is a leading cause of liver-related morbidity and mortality worldwide. After sustained virological response (SVR), the risk of developing hepatocellular carcinoma is not completely eliminated in patients with esta …
Not surprisingly, HCV infection is a leading cause of liver-related morbidity and mortality worldwide. After sustained virological response …
Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C.
Ioannou GN, Green PK, Beste LA, Mun EJ, Kerr KF, Berry K. Ioannou GN, et al. J Hepatol. 2018 Nov;69(5):1088-1098. doi: 10.1016/j.jhep.2018.07.024. Epub 2018 Aug 21. J Hepatol. 2018. PMID: 30138686 Free PMC article.
We aimed to develop models estimating hepatocellular carcinoma (HCC) risk after antiviral treatment. ...CONCLUSIONS: We developed and internally validated models that estimate HCC risk following …
We aimed to develop models estimating hepatocellular carcinoma (HCC) risk after antiviral …
Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents.
Hamoir C, Horsmans Y, Stärkel P, Dahlqvist G, Negrin Dastis S, Lanthier N. Hamoir C, et al. Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):25-32. doi: 10.51821/84.1.420. Acta Gastroenterol Belg. 2021. PMID: 33639690 Free article.
BACKGROUND AND STUDY AIMS: Cirrhosis associated to chronic hepatitis C virus (HCV) is one of the leading cause of hepatocellular carcinoma (HCC). The goal of our study was to evaluate first the risk and determinants of HCC and second the evoluti …
BACKGROUND AND STUDY AIMS: Cirrhosis associated to chronic hepatitis C virus (HCV) is one of the leading cause of hepatocel …
Modelling hepatitis C virus infection and the development of hepatocellular carcinoma.
Chakrabarty SP, Murray JM. Chakrabarty SP, et al. J Theor Biol. 2012 Jul 21;305:24-9. doi: 10.1016/j.jtbi.2012.03.030. Epub 2012 Apr 1. J Theor Biol. 2012. PMID: 22575547
While mathematical models exist describing the dynamics of hepatitis C virus (HCV), most of them focus on the short term dynamics after the commencement of antiviral therapy. ...The risk of cancer arising is modelled through …
While mathematical models exist describing the dynamics of hepatitis C virus (HCV), most of them focus on the short ter …
Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C.
Hayashi T, Ogawa E, Furusyo N, Murata M, Hayashi J. Hayashi T, et al. Infect Agent Cancer. 2016 Feb 24;11:9. doi: 10.1186/s13027-016-0056-y. eCollection 2016. Infect Agent Cancer. 2016. PMID: 26913058 Free PMC article.
BACKGROUND: Insulin resistance is considered to be an important factor in the progression of fibrosis and the enhancement of the risk of hepatocellular carcinoma (HCC) for chronic hepatitis C patients. ...METHODS: This retrospective study …
BACKGROUND: Insulin resistance is considered to be an important factor in the progression of fibrosis and the enhancement of the risk …
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
Nagaoki Y, Imamura M, Aikata H, Daijo K, Teraoka Y, Honda F, Nakamura Y, Hatooka M, Morio R, Morio K, Kan H, Fujino H, Kobayashi T, Masaki K, Ono A, Nakahara T, Kawaoka T, Tsuge M, Hiramatsu A, Kawakami Y, Hayes CN, Miki D, Ochi H, Chayama K. Nagaoki Y, et al. PLoS One. 2017 Aug 10;12(8):e0182710. doi: 10.1371/journal.pone.0182710. eCollection 2017. PLoS One. 2017. PMID: 28797106 Free PMC article.
The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interferon therapy in chronic hepatitis C patients. ...The risk for HCC development following viral eradication b …
The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interfer …
Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
Kim GA, Han S, Kim HD, An J, Lim YS. Kim GA, et al. J Viral Hepat. 2017 Nov;24(11):990-997. doi: 10.1111/jvh.12723. Epub 2017 Jun 9. J Viral Hepat. 2017. PMID: 28499070
It is unclear whether the achievement of virologic response modifies the risk of hepatocellular carcinoma (HCC) differently in chronic hepatitis B (CHB) and chronic hepatitis C (CHC). Our aim was to compare the risk of HCC b …
It is unclear whether the achievement of virologic response modifies the risk of hepatocellular carcinoma (HCC) …
Relation of Reduction of Antibodies against Hepatitis B Virus to Hepatocellular Carcinoma Recurrence in the Patients with Resolved Hepatitis B Virus Infection Following Direct-acting Antiviral Therapy for Hepatitis C Virus Infection.
Joko K, Mashiba T, Ochi H, Yano R, Sato K, Okujima Y, Aono M, Azemoto N, Takechi S, Yokota T, Jinoka R, Moriyama Y, Nishiyama M. Joko K, et al. Euroasian J Hepatogastroenterol. 2019 Jul-Dec;9(2):78-83. doi: 10.5005/jp-journals-10018-1305. Euroasian J Hepatogastroenterol. 2019. PMID: 32117695 Free PMC article.
MATERIALS AND METHODS: The present study examined association of HBV markers with recurrence of hepatocellular carcinoma (HCC) in patients with resolved HCV infection by direct-acting antiviral (DAA) therapy. ...Relation of Reduction of Antibodies agai …
MATERIALS AND METHODS: The present study examined association of HBV markers with recurrence of hepatocellular carcinoma (HCC) …
Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.
Arase Y, Kobayashi M, Suzuki F, Suzuki Y, Kawamura Y, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Kobayashi T. Arase Y, et al. Hepatology. 2013 Mar;57(3):964-73. doi: 10.1002/hep.26087. Epub 2013 Feb 7. Hepatology. 2013. PMID: 22991257
The aim of this retrospective cohort study was to assess the cumulative development incidence and predictive factors for malignancies after the termination of interferon (IFN) therapy in Japanese patients for hepatitis C virus (HCV). ...Evaluation was …
The aim of this retrospective cohort study was to assess the cumulative development incidence and predictive factors for malignancies …
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.
Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, Hiraoka A, Tada F, Ochi H, Kisaka Y, Nakanishi S, Yagi S, Yamauchi K, Higashino M, Hirooka K, Morita M, Okazaki Y, Yukimoto A, Hirooka M, Abe M, Hiasa Y. Watanabe T, et al. Sci Rep. 2023 Jun 2;13(1):8992. doi: 10.1038/s41598-023-36052-0. Sci Rep. 2023. PMID: 37268672 Free PMC article.
The time point of the most precise predictor of hepatocellular carcinoma (HCC) development after viral eradication with direct-acting antiviral (DAA) therapy is unclear. ...The most accurate predictive scoring system to estimate HCC incid …
The time point of the most precise predictor of hepatocellular carcinoma (HCC) development after viral eradication with …
34 results